John Hayslip
Chief Tech/Sci/R&D Officer at VERASTEM, INC.
Profile
John Hayslip is currently the Chief Medical Officer at Verastem, Inc. He previously worked as the Director-Clinical Research & Data Management at The Markey Cancer Center Foundation and as the Vice President-Clinical Development at Nektar Therapeutics.
From 2022 to 2024, he served as the Chief Medical Officer at I-Mab.
Dr. Hayslip holds a graduate degree from the Medical University of South Carolina and a doctorate degree from Northeast Ohio Medical University.
John Hayslip active positions
| Companies | Position | Start |
|---|---|---|
| VERASTEM, INC. | Chief Tech/Sci/R&D Officer | 2024-04-17 |
Former positions of John Hayslip
| Companies | Position | End |
|---|---|---|
| I-MAB | Chief Tech/Sci/R&D Officer | 2024-04-14 |
| The Markey Cancer Center Foundation | Corporate Officer/Principal | - |
| NEKTAR THERAPEUTICS | Chief Tech/Sci/R&D Officer | - |
Training of John Hayslip
| Medical University of South Carolina | Graduate Degree |
| Northeast Ohio Medical University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| NEKTAR THERAPEUTICS | Health Technology |
| VERASTEM, INC. | Health Technology |
| I-MAB | Health Technology |
| Private companies | 1 |
|---|---|
| The Markey Cancer Center Foundation |
- Stock Market
- Insiders
- John Hayslip
